Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Aerosol Pirfenidone Pharmacokinetics after Inhaled Delivery in Sheep: a Viable Approach to Treating Idiopathic Pulmonary Fibrosis.

Kaminskas LM, Landersdorfer CB, Bischof RJ, Leong N, Ibrahim J, Davies AN, Pham S, Beck S, Montgomery AB, Surber MW.

Pharm Res. 2019 Dec 10;37(1):3. doi: 10.1007/s11095-019-2732-2.

PMID:
31823096
2.

Clinical nurse specialist prescribing in a cancer centre supportive and palliative care team.

Hall S, Thompson J, Phair T, Davies AN.

BMJ Support Palliat Care. 2019 Aug 24. pii: bmjspcare-2019-001867. doi: 10.1136/bmjspcare-2019-001867. [Epub ahead of print]

PMID:
31446392
3.

Dealing with complexity: general discussion.

Afonso C, Barrow MP, Bell NGA, Davies AN, Duca D, Focsa C, Gauchotte-Lindsay C, Giusti P, Godfrey R, Goodacre R, Hawkes JA, Hertkorn N, Jansen JJ, Jones D, Kew W, Le Guennec A, Lubben A, Paša-Tolić L, Rodgers RP, Rüger CP, Schmitt-Kopplin P, Schoenmakers PJ, Sciarrone D, Summerfield S, Uhrín D, van Zelst FHM.

Faraday Discuss. 2019 Aug 15;218(0):138-156. doi: 10.1039/C9FD90055A. No abstract available.

PMID:
31384874
4.

Future challenges and new approaches: general discussion.

Afonso C, Chaux C, Davies AN, Delsuc MA, Fernandez Lima F, Gauchotte-Lindsay C, Giusti P, Goodacre R, Hawkes JA, Hertkorn N, Jansen JJ, Kew W, Kuhn S, Lubben A, McGill D, Nilsson M, Parkinson J, Rodgers RP, Rogers S, Schmitt-Kopplin P, Schoenmakers PJ, Shintu L, Soong R, Summerfield S, Surman A, Uhrín D, van der Hooft JJJ.

Faraday Discuss. 2019 Aug 15;218(0):505-523. doi: 10.1039/c9fd90046b. No abstract available.

PMID:
31380556
5.

Data mining and visualisation: general discussion.

Afonso C, Barrow MP, Davies AN, Delsuc MA, Ebbels T, Fernandez-Lima F, Gauchotte-Lindsay C, Giusti P, Goodacre R, Hertkorn N, Jansen JJ, Jones D, Kew W, Kuhn S, Le Guennec A, Lubben A, Parkinson J, Paša-Tolić L, Rogers S, Rudd TR, Schoenmakers PJ, Sidebottom P, Summerfield S, Tinnevelt GH, Trifirò G, Trygg J, van der Hooft JJJ.

Faraday Discuss. 2019 Aug 15;218(0):354-371. doi: 10.1039/C9FD90044F. No abstract available.

PMID:
31373341
6.

High resolution techniques: general discussion.

Adair E, Afonso C, Bell NGA, Davies AN, Delsuc MA, Godfrey R, Goodacre R, Hawkes JA, Hertkorn N, Jones D, Lameiras P, Le Guennec A, Lubben A, Nilsson M, Paša-Tolić L, Richards J, Rodgers RP, Rüger CP, Schmitt-Kopplin P, Schoenmakers PJ, Sidebottom P, Staerk D, Summerfield S, Uhrín D, van Delft P, van der Hooft JJJ, van Zelst FHM, Zherebker A.

Faraday Discuss. 2019 Aug 15;218(0):247-267. doi: 10.1039/c9fd90045d. No abstract available.

PMID:
31369012
7.

Naloxegol for opioid-induced sphincter of Oddi spasm/dysfunction.

Davies AN, Leach C.

BMJ Support Palliat Care. 2019 Dec;9(4):365-366. doi: 10.1136/bmjspcare-2019-001808. Epub 2019 Jun 14.

PMID:
31201151
8.

Assisted dying: the APM should embrace diversity of opinion and encourage sociable debate.

Davies AN.

BMJ. 2019 May 7;365:l1969. doi: 10.1136/bmj.l1969. No abstract available.

PMID:
31064748
9.

Use of headspace-gas chromatography-ion mobility spectrometry to detect volatile fingerprints of palm fibre oil and sludge palm oil in samples of crude palm oil.

Othman A, Goggin KA, Tahir NI, Brodrick E, Singh R, Sambanthamurthi R, Parveez GKA, Davies AN, Murad AJ, Muhammad NH, Ramli US, Murphy DJ.

BMC Res Notes. 2019 Apr 16;12(1):229. doi: 10.1186/s13104-019-4263-7.

10.

Response to 'Does place of death vary by deprivation for patients known to specialist palliative care services?' by Macfarlane and Carduff.

Davies AN, Waghorn M.

BMJ Support Palliat Care. 2019 Sep;9(3):358. doi: 10.1136/bmjspcare-2019-001792. Epub 2019 Apr 3. No abstract available.

PMID:
30944122
11.

Breakthrough cancer pain (BTcP) management: a review of international and national guidelines.

Davies AN, Elsner F, Filbet MJ, Porta-Sales J, Ripamonti C, Santini D, Webber K.

BMJ Support Palliat Care. 2018 Sep;8(3):241-249. doi: 10.1136/bmjspcare-2017-001467. Epub 2018 Jun 6. Review.

PMID:
29875184
12.

Targeting the CACNA1A IRES as a Treatment for Spinocerebellar Ataxia Type 6.

Pastor PDH, Du X, Fazal S, Davies AN, Gomez CM.

Cerebellum. 2018 Feb;17(1):72-77. doi: 10.1007/s12311-018-0917-6.

13.

A cluster randomised feasibility trial of clinically assisted hydration in cancer patients in the last days of life.

Davies AN, Waghorn M, Webber K, Johnsen S, Mendis J, Boyle J.

Palliat Med. 2018 Apr;32(4):733-743. doi: 10.1177/0269216317741572. Epub 2018 Jan 18.

PMID:
29343167
14.

Observational study of sleep disturbances in advanced cancer.

Davies AN, Patel SD, Gregory A, Lee B.

BMJ Support Palliat Care. 2017 Dec;7(4):435-440. doi: 10.1136/bmjspcare-2017-001363. Epub 2017 Aug 23.

PMID:
28835455
15.

Boosting model performance and interpretation by entangling preprocessing selection and variable selection.

Gerretzen J, Szymańska E, Bart J, Davies AN, van Manen HJ, van den Heuvel ER, Jansen JJ, Buydens LM.

Anal Chim Acta. 2016 Sep 28;938:44-52. doi: 10.1016/j.aca.2016.08.022. Epub 2016 Aug 15.

16.

Chemometrics for ion mobility spectrometry data: recent advances and future prospects.

Szymańska E, Davies AN, Buydens LM.

Analyst. 2016 Oct 21;141(20):5689-5708. Epub 2016 Aug 23.

PMID:
27549384
17.

Incorrect Use of the English Language Term "Episodic".

Davies AN, Dickman A, Farquhar-Smith P, Webber K, Zeppetella J.

J Pain Symptom Manage. 2016 Nov;52(5):e1. doi: 10.1016/j.jpainsymman.2016.06.002. Epub 2016 Jul 9. No abstract available.

PMID:
27401518
18.

Increasing conclusiveness of clinical breath analysis by improved baseline correction of multi capillary column - ion mobility spectrometry (MCC-IMS) data.

Szymańska E, Tinnevelt GH, Brodrick E, Williams M, Davies AN, van Manen HJ, Buydens LM.

J Pharm Biomed Anal. 2016 Aug 5;127:170-5. doi: 10.1016/j.jpba.2016.01.054. Epub 2016 Jan 27.

PMID:
26879424
19.

Disparities Between Clinician and Patient Perception of Breakthrough Pain Control.

Webber K, Davies AN, Cowie MR.

J Pain Symptom Manage. 2016 May;51(5):933-937.e2. doi: 10.1016/j.jpainsymman.2015.12.309. Epub 2015 Dec 29.

PMID:
26740387
20.

Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.

Davies AN, Thompson J.

Cochrane Database Syst Rev. 2015 Oct 5;(10):CD003782. doi: 10.1002/14651858.CD003782.pub3. Review.

21.

WITHDRAWN: Opioids for the management of breakthrough pain in cancer patients.

Zeppetella G, Davies AN.

Cochrane Database Syst Rev. 2015 Aug 14;(8):CD004311. doi: 10.1002/14651858.CD004311.pub4. Review. No abstract available.

PMID:
26275024
22.

Accuracy of a Diagnostic Algorithm to Diagnose Breakthrough Cancer Pain as Compared With Clinical Assessment.

Webber K, Davies AN, Cowie MR.

J Pain Symptom Manage. 2015 Oct;50(4):495-500. doi: 10.1016/j.jpainsymman.2015.05.006. Epub 2015 May 27.

PMID:
26025280
23.

Data size reduction strategy for the classification of breath and air samples using multicapillary column-ion mobility spectrometry.

Szymańska E, Brodrick E, Williams M, Davies AN, van Manen HJ, Buydens LM.

Anal Chem. 2015 Jan 20;87(2):869-75. doi: 10.1021/ac503857y. Epub 2015 Jan 8.

PMID:
25519893
24.

Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation.

Camilleri M, Drossman DA, Becker G, Webster LR, Davies AN, Mawe GM.

Neurogastroenterol Motil. 2014 Oct;26(10):1386-95. doi: 10.1111/nmo.12417. Epub 2014 Aug 28. Review.

25.

Palliative care of chronic progressive lung disease.

Patel SA, Davies AN.

Clin Med (Lond). 2014 Jun;14(3):325. doi: 10.7861/clinmedicine.14-3-325. No abstract available.

26.

Development and validation of the breakthrough pain assessment tool (BAT) in cancer patients.

Webber K, Davies AN, Zeppetella G, Cowie MR.

J Pain Symptom Manage. 2014 Oct;48(4):619-31. doi: 10.1016/j.jpainsymman.2013.10.026. Epub 2014 Apr 22.

PMID:
24766740
27.

Breakthrough cancer pain.

Davies AN.

Curr Pain Headache Rep. 2014 Jun;18(6):420. doi: 10.1007/s11916-014-0420-9. Review.

PMID:
24760489
28.

Palliative medicine must accept responsibility for end of life care.

Davies AN.

BMJ. 2013 Dec 4;347:f7159. doi: 10.1136/bmj.f7159. No abstract available.

PMID:
24305434
29.

Opioids for the management of breakthrough pain in cancer patients.

Zeppetella G, Davies AN.

Cochrane Database Syst Rev. 2013 Oct 21;(10):CD004311. doi: 10.1002/14651858.CD004311.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(8):CD004311.

PMID:
24142465
30.

WITHDRAWN: Opioids for the palliation of breathlessness in advanced disease and terminal illness.

Jennings AL, Davies AN, Higgins JP, Anzures-Cabrera J, Broadley KE.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002066. doi: 10.1002/14651858.CD002066.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;(7):CD002066.

PMID:
22786477
31.

Density of microbial colonization on external and internal surfaces of concurrently placed intravascular devices.

Koh DB, Robertson IK, Watts M, Davies AN.

Am J Crit Care. 2012 May;21(3):162-71. doi: 10.4037/ajcc2012675.

PMID:
22549572
32.

The management of breakthrough cancer pain.

Davies AN.

Br J Nurs. 2011 Jul 15-28;20(13):803-4, 806-7.

PMID:
21841688
33.

An observational study to determine the prevalence of alcohol use disorders in advanced cancer patients.

Webber K, Davies AN.

Palliat Med. 2012 Jun;26(4):360-7. doi: 10.1177/0269216311409474. Epub 2011 May 23.

PMID:
21606126
34.

Validity of the memorial symptom assessment scale-short form psychological subscales in advanced cancer patients.

Webber K, Davies AN.

J Pain Symptom Manage. 2011 Nov;42(5):761-7. doi: 10.1016/j.jpainsymman.2011.02.007. Epub 2011 May 6.

PMID:
21530154
35.

Breakthrough pain: a qualitative study involving patients with advanced cancer.

Webber K, Davies AN, Cowie MR.

Support Care Cancer. 2011 Dec;19(12):2041-6. doi: 10.1007/s00520-010-1062-z. Epub 2010 Dec 22.

PMID:
21181210
36.
37.

A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.

Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT; Salivary Gland Hypofunction/Xerostomia Section; Oral Care Study Group; Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO).

Support Care Cancer. 2010 Aug;18(8):1061-79. doi: 10.1007/s00520-010-0837-6. Epub 2010 Mar 25. Review.

PMID:
20333412
38.

A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.

Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT; Salivary Gland Hypofunction/Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO).

Support Care Cancer. 2010 Aug;18(8):1039-60. doi: 10.1007/s00520-010-0827-8. Epub 2010 Mar 17. Review.

PMID:
20237805
39.

Paraneoplastic Raynaud's phenomenon--good palliation after a multidisciplinary approach.

Schildmann EK, Davies AN.

J Pain Symptom Manage. 2010 Apr;39(4):779-83. doi: 10.1016/j.jpainsymman.2009.09.006. Epub 2010 Mar 3.

PMID:
20199852
40.

Sleep-wake disturbances in patients with advanced cancer and their family carers.

Gibbins J, McCoubrie R, Kendrick AH, Senior-Smith G, Davies AN, Hanks GW.

J Pain Symptom Manage. 2009 Dec;38(6):860-70. doi: 10.1016/j.jpainsymman.2009.04.025.

PMID:
19800196
41.

Breakthrough cancer pain.

Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G; Science Committee of the Association for Palliative Medicine of Great Britain and Ireland.

BMJ. 2008 Nov 25;337:a2689. doi: 10.1136/bmj.a2689. No abstract available.

PMID:
19033342
42.

The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland.

Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G; Science Committee of the Association for Palliative Medicine of Great Britain and Ireland.

Eur J Pain. 2009 Apr;13(4):331-8. doi: 10.1016/j.ejpain.2008.06.014. Epub 2008 Aug 15.

PMID:
18707904
43.

Oral candidosis in community-based patients with advanced cancer.

Davies AN, Brailsford SR, Beighton D, Shorthose K, Stevens VC.

J Pain Symptom Manage. 2008 May;35(5):508-14. doi: 10.1016/j.jpainsymman.2007.07.005. Epub 2008 Feb 1.

PMID:
18242047
44.

An observational study of oncology patients' utilization of breakthrough pain medication.

Davies AN, Vriens J, Kennett A, McTaggart M.

J Pain Symptom Manage. 2008 Apr;35(4):406-11. doi: 10.1016/j.jpainsymman.2007.05.010. Epub 2008 Jan 28.

PMID:
18222631
45.

Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.

Davies AN, Shorthose K.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003782. Review. Update in: Cochrane Database Syst Rev. 2015;10:CD003782.

PMID:
17636736
46.

Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates.

Hume SP, Lingford-Hughes AR, Nataf V, Hirani E, Ahmad R, Davies AN, Nutt DJ.

J Pharmacol Exp Ther. 2007 Aug;322(2):661-7. Epub 2007 May 8.

PMID:
17488881
47.

Cancer-related breakthrough pain.

Davies AN.

Br J Hosp Med (Lond). 2006 Aug;67(8):414-6. Review.

PMID:
16918095
48.

Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials.

Reid CM, Martin RM, Sterne JA, Davies AN, Hanks GW.

Arch Intern Med. 2006 Apr 24;166(8):837-43. Erratum in: Arch Intern Med. 2006 Nov 27;166(21):2387.

PMID:
16636208
49.

Oral candidosis in patients with advanced cancer.

Davies AN, Brailsford SR, Beighton D.

Oral Oncol. 2006 Aug;42(7):698-702. Epub 2006 Mar 9.

PMID:
16527512
50.

Susceptibility to Melaleuca alternifolia (tea tree) oil of yeasts isolated from the mouths of patients with advanced cancer.

Bagg J, Jackson MS, Petrina Sweeney M, Ramage G, Davies AN.

Oral Oncol. 2006 May;42(5):487-92. Epub 2006 Feb 20.

PMID:
16488180

Supplemental Content

Loading ...
Support Center